臨床診斷市場：按測試、按產品、按最終用戶、按地區 - 規模、份額、展望、機會分析，2022-2028 年

臨床診斷是根據患者的體徵和症狀、患者的病史和體格檢查來識別疾病、狀況或損傷的過程。 臨床診斷也被證明可用於疾病的預防、檢測和管理。 這些測試有助於檢測和監測許多醫療狀況，包括慢性、傳染性和自身免疫性疾病，並用於分析藥物療法。

市場動態

慢性病和傳染病的負擔不斷增加、臨床診斷的利用率增加、老年人口不斷增加、研究和開發不斷增加、COVID-19 的全球爆發等都將推動全球臨床診斷市場的增長。

例如，2020 年 9 月，美國國立衛生研究院 (NIH) 作為其快速加速診斷 (RADx) 計劃的一部分，擴大規模以支持製造一套新的 COVID-19 測試技術, 9計劃向該公司投資1.293億美元。 此外，2020 年 3 月，在歐盟委員會的研究和創新框架 Horizo□□n 2020 的支持下，創新藥物計劃 (IMI) 宣布將向五個致力於創新其診斷組合的組織提供 7200 萬歐元的資金。

這項研究的主要特點

• 本報告對全球臨床診斷市場進行了深入分析，提供了以 2021 年為基準年的預測期 (2022-2028) 的市場規模和復合年增長率 (CAGR%)。.
• 它還闡明了各個細分市場的潛在創收機會，並描述了針對該市場的一系列有吸引力的投資建議。
• 它還提供了有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景、主要參與者採用的競爭戰略等方面的重要見解。
• 根據以下參數對全球臨床診斷市場的主要參與者進行了概況分析，包括公司亮點、產品組合、主要亮點、績效和戰略。
• 本研究涵蓋的主要公司包括 Thermo Fisher Scientific、Qiagen N.V、Hologic Inc.、Siemens Healthineers AG、BioMerieux SA、Abbott Laboratories、Bio-Rad Laboratories Inc.、F. Hoffmann-La Roche AG、Becton、 Dickinson and Company 和 Danaher Corporation (Beckman Coulter, Inc.) 等。
• 這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。我猜。
• 《全球臨床診斷市場》報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利益相關者可以通過用於分析全球臨床診斷市場的各種戰略矩陣來促進決策制定。

內容

第 1 章目的和先決條件

• 調查目的
• 先決條件
• 縮寫說明

第二章市場展望

• 報告內容
  • 市場定義和範圍
• 執行摘要
  • 市場概況：按類型分類
  • 市場概況：按產品分類
  • 市場概況：按最終用戶分類
  • 市場概況：按地區
• 連貫機會圖 (COM)

第3章市場動態、規律及趨勢分析

• 市場動態
  • 全球傳染病和慢性病負擔日益加重
  • 高端分子診斷試劑的成本更高
  • COVID-19 爆發（全球大流行）
• 影響分析
• 主要亮點
• 監管情景
• 產品發布/批准
• 害蟲分析
• 對 PORTER 的分析
• 合併/收購場景

第 4 章全球臨床診斷市場 - 冠狀病毒 (COVID-19) 大流行的影響

• COVID-19 的流行病學特徵
• 供應方和需求方分析
• 經濟影響

第 5 章全球臨床診斷市場：按類型，2017-2028

• 脂質組
• 肝板
• 腎臟面板
• 全血細胞計數
• 電解質測試
• 傳染病檢測
• 其他測試

第 6 章全球臨床診斷市場：按產品分類，2017-2028

• 檢驗設備
• 試劑
• 其他產品

第 7 章全球臨床診斷市場：按最終用戶分類，2017-2028

• 醫院檢查室
• 診斷實驗室
• 即時檢測
• 其他最終用戶

第 8 章按地區分列的全球臨床診斷市場，2017-2028

• 北美
• 歐洲
• 亞太地區
• 拉丁美洲
• 中東和非洲
• 世界其他地方

第9章競爭格局

• Thermo Fisher Scientific
• F. Hoffmann-La Roche AG
• Qiagen N.V
• Hologic Inc.
• Siemens Healthineers AG
• BioMerieux SA
• Abbott Laboratories
• Bio-Rad Laboratories Inc.
• Becton, Dickinson and Company
• Danaher Corporation（Beckman Coulter, Inc.）

第 10 章

• 調查方法介紹
• 關於出版商

Clinical diagnostic is the process of identifying a disease, condition, or injury based on the signs & symptoms a patient is having and patient's health history and physical exam. Clinical diagnostics have been also found to be valuable for the prevention, detection, and management of the disease. These tests help detect and monitor many medical conditions, such as chronic diseases, infectious diseases, and autoimmune diseases that are being used to analyze drug therapies.

Market Dynamics:

Growing burden of chronic and infectious diseases, increase in use of clinical diagnostic, growing geriatric population, increase in research and development, and outbreak of COVID-19 worldwide are expected to drive growth of the global clinical diagnostic market.

For instance, in September 2020, the National Institutes of Health (NIH) planned to give a funding of US$ 129.3 million to 9 companies to scale-up manufacturing support for a new set of COVID-19 testing technologies as part of Rapid Acceleration of Diagnostics (RADx) initiative. Moreover, in March 2020, Innovative Medicines Initiative (IMI), supported by the European Commission's Horizon 2020 Framework Programme for Research and Innovation, announced EUR 72 million funding to five organizations working to innovate diagnostic portfolios.

Key features of the study:

• This report provides in-depth analysis of the global clinical diagnostic market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global clinical diagnostic market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Thermo Fisher Scientific, Qiagen N.V, Hologic Inc., Siemens Healthineers AG, BioMerieux SA, Abbott Laboratories, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Becton, Dickinson and Company, and Danaher Corporation (Beckman Coulter, Inc.), among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global clinical diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global clinical diagnostic market.

Detailed Segmentation:

• Global Clinical Diagnostic Market, By Test:
  • Lipid Panel
  • Liver Panel
  • Renal Panel
  • Complete Blood Count
  • Electrolyte Testing
  • Infectious Disease Testing
  • Other Tests
• Global Clinical Diagnostic Market, By Product:
  • Instruments
  • Reagents
  • Other Products
• Global Clinical Diagnostic Market, By End User:
  • Hospital Laboratory
  • Diagnostic Laboratory
  • Point-of-Care Testing
  • Other End Users
• Global Clinical Diagnostic Market, By Geography:
  • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
  • South America
• Company Profiles:
  • Thermo Fisher Scientific
  • F.Hoffmann-La Roche AG
  • Qiagen N.V
  • Hologic Inc.
  • Siemens Healthineers AG
  • BioMerieux SA
  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • Becton, Dickinson and Company
  • Danaher Corporation (Beckman Coulter, Inc.)

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Product
  • Market Snapshot, By End User
  • Market Snapshot, By Geography
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Growing burden of infectious and chronic diseases worldwide
  • High cost of high-end molecular diagnostics
  • The outbreak of COVID-19 (global pandemic)
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Clinical Diagnostic Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Clinical Diagnostic Market, By Type, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Lipid Panel
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Liver Panel
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Renal Panel
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Complete Blood Count
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Electrolyte Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Infectious Disease Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Other Tests
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

6. Global Clinical Diagnostic Market, By Product, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Instruments
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Reagents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Other Products
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

7. Global Clinical Diagnostic Market, By End User, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Hospital Laboratory
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Diagnostic Laboratory
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Point-of-Care Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Other End Users
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

8. Global Clinical Diagnostic Market, By Geography, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Middle East and Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Rest of World
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)

9. Competitive Landscape

• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• F. Hoffmann-La Roche AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Qiagen N.V
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hologic Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Siemens Healthineers AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• BioMerieux SA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Becton, Dickinson and Company
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Danaher Corporation (Beckman Coulter, Inc.)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us